nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP1A2—Pentoxifylline—systemic scleroderma	0.141	0.297	CbGbCtD
Alosetron—CYP1A2—Leflunomide—systemic scleroderma	0.135	0.283	CbGbCtD
Alosetron—CYP2C9—Leflunomide—systemic scleroderma	0.121	0.255	CbGbCtD
Alosetron—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0436	0.0916	CbGbCtD
Alosetron—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0419	0.448	CbGeAlD
Alosetron—CYP2C9—cardial valve—systemic scleroderma	0.0359	0.384	CbGeAlD
Alosetron—CYP3A4—Prednisone—systemic scleroderma	0.0348	0.0733	CbGbCtD
Alosetron—HTR3A—digestive system—systemic scleroderma	0.00317	0.0339	CbGeAlD
Alosetron—HTR3A—lung—systemic scleroderma	0.00265	0.0283	CbGeAlD
Alosetron—CYP1A2—digestive system—systemic scleroderma	0.00164	0.0175	CbGeAlD
Alosetron—CYP2C9—digestive system—systemic scleroderma	0.00156	0.0166	CbGeAlD
Alosetron—CYP2E1—digestive system—systemic scleroderma	0.00147	0.0158	CbGeAlD
Alosetron—CYP2E1—tendon—systemic scleroderma	0.0014	0.015	CbGeAlD
Alosetron—CYP1A2—lung—systemic scleroderma	0.00137	0.0146	CbGeAlD
Alosetron—CYP2E1—lung—systemic scleroderma	0.00123	0.0132	CbGeAlD
Alosetron—CYP3A4—digestive system—systemic scleroderma	0.00119	0.0127	CbGeAlD
Alosetron—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000837	0.00194	CcSEcCtD
Alosetron—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000837	0.00194	CcSEcCtD
Alosetron—Malaise—Captopril—systemic scleroderma	0.000835	0.00194	CcSEcCtD
Alosetron—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.000832	0.00193	CcSEcCtD
Alosetron—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.00083	0.00193	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Methotrexate—systemic scleroderma	0.00083	0.00193	CcSEcCtD
Alosetron—Arrhythmia—Azathioprine—systemic scleroderma	0.000829	0.00193	CcSEcCtD
Alosetron—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000822	0.00191	CcSEcCtD
Alosetron—Alopecia—Azathioprine—systemic scleroderma	0.00082	0.0019	CcSEcCtD
Alosetron—Jaundice—Lisinopril—systemic scleroderma	0.000818	0.0019	CcSEcCtD
Alosetron—Urinary tract infection—Lisinopril—systemic scleroderma	0.000816	0.00189	CcSEcCtD
Alosetron—Cough—Captopril—systemic scleroderma	0.000808	0.00188	CcSEcCtD
Alosetron—Sweating—Lisinopril—systemic scleroderma	0.000805	0.00187	CcSEcCtD
Alosetron—Urticaria—Pentoxifylline—systemic scleroderma	0.000792	0.00184	CcSEcCtD
Alosetron—Myalgia—Captopril—systemic scleroderma	0.000788	0.00183	CcSEcCtD
Alosetron—Sinusitis—Lisinopril—systemic scleroderma	0.000787	0.00183	CcSEcCtD
Alosetron—Ulcer—Methotrexate—systemic scleroderma	0.000787	0.00183	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000784	0.00182	CcSEcCtD
Alosetron—Arrhythmia—Leflunomide—systemic scleroderma	0.000783	0.00182	CcSEcCtD
Alosetron—Discomfort—Captopril—systemic scleroderma	0.000779	0.00181	CcSEcCtD
Alosetron—Alopecia—Leflunomide—systemic scleroderma	0.000775	0.0018	CcSEcCtD
Alosetron—Dry mouth—Captopril—systemic scleroderma	0.000771	0.00179	CcSEcCtD
Alosetron—Confusional state—Captopril—systemic scleroderma	0.000762	0.00177	CcSEcCtD
Alosetron—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.000762	0.00177	CcSEcCtD
Alosetron—Hepatitis—Lisinopril—systemic scleroderma	0.000753	0.00175	CcSEcCtD
Alosetron—Flatulence—Leflunomide—systemic scleroderma	0.000752	0.00175	CcSEcCtD
Alosetron—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00075	0.00174	CcSEcCtD
Alosetron—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000747	0.00173	CcSEcCtD
Alosetron—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00173	CcSEcCtD
Alosetron—Fatigue—Mometasone—systemic scleroderma	0.000742	0.00172	CcSEcCtD
Alosetron—Alopecia—Mycophenolic acid—systemic scleroderma	0.000739	0.00172	CcSEcCtD
Alosetron—Pain—Mometasone—systemic scleroderma	0.000736	0.00171	CcSEcCtD
Alosetron—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000735	0.00171	CcSEcCtD
Alosetron—Muscle spasms—Leflunomide—systemic scleroderma	0.000734	0.0017	CcSEcCtD
Alosetron—Depression—Mycophenolate mofetil—systemic scleroderma	0.000733	0.0017	CcSEcCtD
Alosetron—Malaise—Azathioprine—systemic scleroderma	0.000729	0.00169	CcSEcCtD
Alosetron—Cystitis noninfective—Methotrexate—systemic scleroderma	0.000727	0.00169	CcSEcCtD
Alosetron—Cystitis—Methotrexate—systemic scleroderma	0.000719	0.00167	CcSEcCtD
Alosetron—Flatulence—Mycophenolic acid—systemic scleroderma	0.000718	0.00167	CcSEcCtD
Alosetron—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000717	0.00166	CcSEcCtD
Alosetron—Asthenia—Pentoxifylline—systemic scleroderma	0.000716	0.00166	CcSEcCtD
Alosetron—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00166	CcSEcCtD
Alosetron—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000708	0.00164	CcSEcCtD
Alosetron—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000705	0.00164	CcSEcCtD
Alosetron—Injury—Prednisone—systemic scleroderma	0.000704	0.00163	CcSEcCtD
Alosetron—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.0007	0.00162	CcSEcCtD
Alosetron—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00069	0.0016	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000689	0.0016	CcSEcCtD
Alosetron—Malaise—Leflunomide—systemic scleroderma	0.000688	0.0016	CcSEcCtD
Alosetron—Myalgia—Azathioprine—systemic scleroderma	0.000688	0.0016	CcSEcCtD
Alosetron—Tremor—Mycophenolic acid—systemic scleroderma	0.000682	0.00158	CcSEcCtD
Alosetron—Discomfort—Azathioprine—systemic scleroderma	0.00068	0.00158	CcSEcCtD
Alosetron—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000676	0.00157	CcSEcCtD
Alosetron—Urine output increased—Methotrexate—systemic scleroderma	0.000673	0.00156	CcSEcCtD
Alosetron—Bladder pain—Methotrexate—systemic scleroderma	0.000673	0.00156	CcSEcCtD
Alosetron—Arrhythmia—Lisinopril—systemic scleroderma	0.000673	0.00156	CcSEcCtD
Alosetron—Cough—Leflunomide—systemic scleroderma	0.000666	0.00155	CcSEcCtD
Alosetron—Alopecia—Lisinopril—systemic scleroderma	0.000666	0.00155	CcSEcCtD
Alosetron—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00154	CcSEcCtD
Alosetron—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00066	0.00153	CcSEcCtD
Alosetron—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00066	0.00153	CcSEcCtD
Alosetron—Hypertension—Leflunomide—systemic scleroderma	0.000659	0.00153	CcSEcCtD
Alosetron—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000657	0.00152	CcSEcCtD
Alosetron—Malaise—Mycophenolic acid—systemic scleroderma	0.000657	0.00152	CcSEcCtD
Alosetron—Infection—Azathioprine—systemic scleroderma	0.000655	0.00152	CcSEcCtD
Alosetron—Fatigue—Captopril—systemic scleroderma	0.000652	0.00151	CcSEcCtD
Alosetron—Myalgia—Leflunomide—systemic scleroderma	0.00065	0.00151	CcSEcCtD
Alosetron—Anxiety—Leflunomide—systemic scleroderma	0.000648	0.0015	CcSEcCtD
Alosetron—Constipation—Captopril—systemic scleroderma	0.000646	0.0015	CcSEcCtD
Alosetron—Flatulence—Lisinopril—systemic scleroderma	0.000646	0.0015	CcSEcCtD
Alosetron—Discomfort—Leflunomide—systemic scleroderma	0.000642	0.00149	CcSEcCtD
Alosetron—Skin disorder—Azathioprine—systemic scleroderma	0.000641	0.00149	CcSEcCtD
Alosetron—Dry mouth—Leflunomide—systemic scleroderma	0.000636	0.00148	CcSEcCtD
Alosetron—Cough—Mycophenolic acid—systemic scleroderma	0.000635	0.00147	CcSEcCtD
Alosetron—Vomiting—Pentoxifylline—systemic scleroderma	0.000634	0.00147	CcSEcCtD
Alosetron—Muscle spasms—Lisinopril—systemic scleroderma	0.000631	0.00146	CcSEcCtD
Alosetron—Rash—Pentoxifylline—systemic scleroderma	0.000629	0.00146	CcSEcCtD
Alosetron—Hypertension—Mycophenolic acid—systemic scleroderma	0.000629	0.00146	CcSEcCtD
Alosetron—Dermatitis—Pentoxifylline—systemic scleroderma	0.000628	0.00146	CcSEcCtD
Alosetron—Headache—Pentoxifylline—systemic scleroderma	0.000625	0.00145	CcSEcCtD
Alosetron—Feeling abnormal—Captopril—systemic scleroderma	0.000623	0.00145	CcSEcCtD
Alosetron—Myalgia—Mycophenolic acid—systemic scleroderma	0.00062	0.00144	CcSEcCtD
Alosetron—Infection—Leflunomide—systemic scleroderma	0.000619	0.00144	CcSEcCtD
Alosetron—Anxiety—Mycophenolic acid—systemic scleroderma	0.000618	0.00143	CcSEcCtD
Alosetron—Asthenia—Mometasone—systemic scleroderma	0.000617	0.00143	CcSEcCtD
Alosetron—Polyuria—Methotrexate—systemic scleroderma	0.000616	0.00143	CcSEcCtD
Alosetron—Tremor—Lisinopril—systemic scleroderma	0.000615	0.00143	CcSEcCtD
Alosetron—Discomfort—Mycophenolic acid—systemic scleroderma	0.000613	0.00142	CcSEcCtD
Alosetron—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000609	0.00141	CcSEcCtD
Alosetron—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000606	0.00141	CcSEcCtD
Alosetron—Skin disorder—Leflunomide—systemic scleroderma	0.000605	0.0014	CcSEcCtD
Alosetron—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000602	0.0014	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000601	0.00139	CcSEcCtD
Alosetron—Confusional state—Mycophenolic acid—systemic scleroderma	0.000599	0.00139	CcSEcCtD
Alosetron—Nausea—Pentoxifylline—systemic scleroderma	0.000592	0.00137	CcSEcCtD
Alosetron—Malaise—Lisinopril—systemic scleroderma	0.000591	0.00137	CcSEcCtD
Alosetron—Infection—Mycophenolic acid—systemic scleroderma	0.00059	0.00137	CcSEcCtD
Alosetron—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00137	CcSEcCtD
Alosetron—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00135	CcSEcCtD
Alosetron—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000577	0.00134	CcSEcCtD
Alosetron—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000575	0.00133	CcSEcCtD
Alosetron—Cough—Lisinopril—systemic scleroderma	0.000572	0.00133	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000571	0.00132	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000568	0.00132	CcSEcCtD
Alosetron—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000566	0.00131	CcSEcCtD
Alosetron—Abdominal distension—Prednisone—systemic scleroderma	0.000563	0.00131	CcSEcCtD
Alosetron—Myalgia—Lisinopril—systemic scleroderma	0.000558	0.0013	CcSEcCtD
Alosetron—Anxiety—Lisinopril—systemic scleroderma	0.000556	0.00129	CcSEcCtD
Alosetron—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00128	CcSEcCtD
Alosetron—Discomfort—Lisinopril—systemic scleroderma	0.000552	0.00128	CcSEcCtD
Alosetron—Vomiting—Mometasone—systemic scleroderma	0.000547	0.00127	CcSEcCtD
Alosetron—Dry mouth—Lisinopril—systemic scleroderma	0.000546	0.00127	CcSEcCtD
Alosetron—Feeling abnormal—Azathioprine—systemic scleroderma	0.000544	0.00126	CcSEcCtD
Alosetron—Rash—Mometasone—systemic scleroderma	0.000543	0.00126	CcSEcCtD
Alosetron—Asthenia—Captopril—systemic scleroderma	0.000542	0.00126	CcSEcCtD
Alosetron—Dermatitis—Mometasone—systemic scleroderma	0.000542	0.00126	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000541	0.00126	CcSEcCtD
Alosetron—Confusional state—Lisinopril—systemic scleroderma	0.00054	0.00125	CcSEcCtD
Alosetron—Headache—Mometasone—systemic scleroderma	0.000539	0.00125	CcSEcCtD
Alosetron—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00125	CcSEcCtD
Alosetron—Fatigue—Leflunomide—systemic scleroderma	0.000537	0.00125	CcSEcCtD
Alosetron—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000533	0.00124	CcSEcCtD
Alosetron—Constipation—Leflunomide—systemic scleroderma	0.000533	0.00124	CcSEcCtD
Alosetron—Pain—Leflunomide—systemic scleroderma	0.000533	0.00124	CcSEcCtD
Alosetron—Infection—Lisinopril—systemic scleroderma	0.000532	0.00123	CcSEcCtD
Alosetron—Skin disorder—Lisinopril—systemic scleroderma	0.00052	0.00121	CcSEcCtD
Alosetron—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000518	0.0012	CcSEcCtD
Alosetron—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000517	0.0012	CcSEcCtD
Alosetron—Feeling abnormal—Leflunomide—systemic scleroderma	0.000513	0.00119	CcSEcCtD
Alosetron—Fatigue—Mycophenolic acid—systemic scleroderma	0.000512	0.00119	CcSEcCtD
Alosetron—Nausea—Mometasone—systemic scleroderma	0.000511	0.00119	CcSEcCtD
Alosetron—Pain—Mycophenolic acid—systemic scleroderma	0.000508	0.00118	CcSEcCtD
Alosetron—Constipation—Mycophenolic acid—systemic scleroderma	0.000508	0.00118	CcSEcCtD
Alosetron—Hyperglycaemia—Prednisone—systemic scleroderma	0.000504	0.00117	CcSEcCtD
Alosetron—Cough—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00116	CcSEcCtD
Alosetron—Depression—Prednisone—systemic scleroderma	0.000497	0.00115	CcSEcCtD
Alosetron—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000496	0.00115	CcSEcCtD
Alosetron—Urticaria—Leflunomide—systemic scleroderma	0.000495	0.00115	CcSEcCtD
Alosetron—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00049	0.00114	CcSEcCtD
Alosetron—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000489	0.00114	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000488	0.00113	CcSEcCtD
Alosetron—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000488	0.00113	CcSEcCtD
Alosetron—Hypersensitivity—Azathioprine—systemic scleroderma	0.000486	0.00113	CcSEcCtD
Alosetron—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00112	CcSEcCtD
Alosetron—Vomiting—Captopril—systemic scleroderma	0.000481	0.00112	CcSEcCtD
Alosetron—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000478	0.00111	CcSEcCtD
Alosetron—Rash—Captopril—systemic scleroderma	0.000477	0.00111	CcSEcCtD
Alosetron—Dermatitis—Captopril—systemic scleroderma	0.000476	0.00111	CcSEcCtD
Alosetron—Headache—Captopril—systemic scleroderma	0.000474	0.0011	CcSEcCtD
Alosetron—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000473	0.0011	CcSEcCtD
Alosetron—Infection—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00108	CcSEcCtD
Alosetron—Fatigue—Lisinopril—systemic scleroderma	0.000462	0.00107	CcSEcCtD
Alosetron—Hypersensitivity—Leflunomide—systemic scleroderma	0.000459	0.00107	CcSEcCtD
Alosetron—Pain—Lisinopril—systemic scleroderma	0.000458	0.00106	CcSEcCtD
Alosetron—Constipation—Lisinopril—systemic scleroderma	0.000458	0.00106	CcSEcCtD
Alosetron—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00106	CcSEcCtD
Alosetron—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000453	0.00105	CcSEcCtD
Alosetron—Haemoglobin—Prednisone—systemic scleroderma	0.00045	0.00104	CcSEcCtD
Alosetron—Nausea—Captopril—systemic scleroderma	0.000449	0.00104	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000448	0.00104	CcSEcCtD
Alosetron—Haemorrhage—Prednisone—systemic scleroderma	0.000447	0.00104	CcSEcCtD
Alosetron—Asthenia—Leflunomide—systemic scleroderma	0.000447	0.00104	CcSEcCtD
Alosetron—Feeling abnormal—Lisinopril—systemic scleroderma	0.000441	0.00102	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000434	0.00101	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000992	CcSEcCtD
Alosetron—Asthenia—Mycophenolic acid—systemic scleroderma	0.000426	0.00099	CcSEcCtD
Alosetron—Urticaria—Lisinopril—systemic scleroderma	0.000425	0.000987	CcSEcCtD
Alosetron—Vomiting—Azathioprine—systemic scleroderma	0.000419	0.000973	CcSEcCtD
Alosetron—Rash—Azathioprine—systemic scleroderma	0.000416	0.000965	CcSEcCtD
Alosetron—Dermatitis—Azathioprine—systemic scleroderma	0.000416	0.000964	CcSEcCtD
Alosetron—Depression—Methotrexate—systemic scleroderma	0.000415	0.000964	CcSEcCtD
Alosetron—Headache—Azathioprine—systemic scleroderma	0.000413	0.000959	CcSEcCtD
Alosetron—Pain—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000931	CcSEcCtD
Alosetron—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000931	CcSEcCtD
Alosetron—Arrhythmia—Prednisone—systemic scleroderma	0.0004	0.000928	CcSEcCtD
Alosetron—Sweating—Methotrexate—systemic scleroderma	0.000399	0.000927	CcSEcCtD
Alosetron—Vomiting—Leflunomide—systemic scleroderma	0.000396	0.000919	CcSEcCtD
Alosetron—Alopecia—Prednisone—systemic scleroderma	0.000395	0.000918	CcSEcCtD
Alosetron—Hypersensitivity—Lisinopril—systemic scleroderma	0.000394	0.000915	CcSEcCtD
Alosetron—Rash—Leflunomide—systemic scleroderma	0.000393	0.000912	CcSEcCtD
Alosetron—Dermatitis—Leflunomide—systemic scleroderma	0.000392	0.000911	CcSEcCtD
Alosetron—Nausea—Azathioprine—systemic scleroderma	0.000392	0.000909	CcSEcCtD
Alosetron—Headache—Leflunomide—systemic scleroderma	0.00039	0.000906	CcSEcCtD
Alosetron—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000897	CcSEcCtD
Alosetron—Asthenia—Lisinopril—systemic scleroderma	0.000384	0.000891	CcSEcCtD
Alosetron—Vomiting—Mycophenolic acid—systemic scleroderma	0.000378	0.000877	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—systemic scleroderma	0.000376	0.000872	CcSEcCtD
Alosetron—Rash—Mycophenolic acid—systemic scleroderma	0.000375	0.00087	CcSEcCtD
Alosetron—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000374	0.000869	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—systemic scleroderma	0.000374	0.000868	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—systemic scleroderma	0.000374	0.000868	CcSEcCtD
Alosetron—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000865	CcSEcCtD
Alosetron—Headache—Mycophenolic acid—systemic scleroderma	0.000372	0.000864	CcSEcCtD
Alosetron—Nausea—Leflunomide—systemic scleroderma	0.00037	0.000859	CcSEcCtD
Alosetron—Ill-defined disorder—Prednisone—systemic scleroderma	0.000361	0.000839	CcSEcCtD
Alosetron—Nausea—Mycophenolic acid—systemic scleroderma	0.000353	0.000819	CcSEcCtD
Alosetron—Malaise—Prednisone—systemic scleroderma	0.000351	0.000815	CcSEcCtD
Alosetron—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000802	CcSEcCtD
Alosetron—Vomiting—Lisinopril—systemic scleroderma	0.00034	0.00079	CcSEcCtD
Alosetron—Rash—Lisinopril—systemic scleroderma	0.000338	0.000783	CcSEcCtD
Alosetron—Dermatitis—Lisinopril—systemic scleroderma	0.000337	0.000783	CcSEcCtD
Alosetron—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000781	CcSEcCtD
Alosetron—Hypertension—Prednisone—systemic scleroderma	0.000336	0.000781	CcSEcCtD
Alosetron—Headache—Lisinopril—systemic scleroderma	0.000335	0.000778	CcSEcCtD
Alosetron—Myalgia—Prednisone—systemic scleroderma	0.000332	0.00077	CcSEcCtD
Alosetron—Anxiety—Prednisone—systemic scleroderma	0.00033	0.000767	CcSEcCtD
Alosetron—Alopecia—Methotrexate—systemic scleroderma	0.00033	0.000767	CcSEcCtD
Alosetron—Discomfort—Prednisone—systemic scleroderma	0.000328	0.00076	CcSEcCtD
Alosetron—Nausea—Lisinopril—systemic scleroderma	0.000318	0.000738	CcSEcCtD
Alosetron—Infection—Prednisone—systemic scleroderma	0.000316	0.000733	CcSEcCtD
Alosetron—Skin disorder—Prednisone—systemic scleroderma	0.000309	0.000717	CcSEcCtD
Alosetron—Hyperhidrosis—Prednisone—systemic scleroderma	0.000307	0.000713	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000302	0.000701	CcSEcCtD
Alosetron—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000692	CcSEcCtD
Alosetron—Rash—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000686	CcSEcCtD
Alosetron—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000686	CcSEcCtD
Alosetron—Headache—Mycophenolate mofetil—systemic scleroderma	0.000294	0.000682	CcSEcCtD
Alosetron—Malaise—Methotrexate—systemic scleroderma	0.000294	0.000681	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00029	0.000672	CcSEcCtD
Alosetron—Cough—Methotrexate—systemic scleroderma	0.000284	0.000659	CcSEcCtD
Alosetron—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000647	CcSEcCtD
Alosetron—Myalgia—Methotrexate—systemic scleroderma	0.000277	0.000643	CcSEcCtD
Alosetron—Fatigue—Prednisone—systemic scleroderma	0.000274	0.000636	CcSEcCtD
Alosetron—Discomfort—Methotrexate—systemic scleroderma	0.000274	0.000636	CcSEcCtD
Alosetron—Constipation—Prednisone—systemic scleroderma	0.000272	0.000631	CcSEcCtD
Alosetron—Confusional state—Methotrexate—systemic scleroderma	0.000268	0.000622	CcSEcCtD
Alosetron—Infection—Methotrexate—systemic scleroderma	0.000264	0.000613	CcSEcCtD
Alosetron—Feeling abnormal—Prednisone—systemic scleroderma	0.000262	0.000608	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—systemic scleroderma	0.000258	0.000599	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000257	0.000596	CcSEcCtD
Alosetron—Urticaria—Prednisone—systemic scleroderma	0.000253	0.000586	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000242	0.000562	CcSEcCtD
Alosetron—Hypersensitivity—Prednisone—systemic scleroderma	0.000234	0.000544	CcSEcCtD
Alosetron—Fatigue—Methotrexate—systemic scleroderma	0.000229	0.000532	CcSEcCtD
Alosetron—Asthenia—Prednisone—systemic scleroderma	0.000228	0.000529	CcSEcCtD
Alosetron—Pain—Methotrexate—systemic scleroderma	0.000227	0.000527	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—systemic scleroderma	0.000219	0.000508	CcSEcCtD
Alosetron—Urticaria—Methotrexate—systemic scleroderma	0.000211	0.00049	CcSEcCtD
Alosetron—Vomiting—Prednisone—systemic scleroderma	0.000202	0.000469	CcSEcCtD
Alosetron—Rash—Prednisone—systemic scleroderma	0.0002	0.000465	CcSEcCtD
Alosetron—Dermatitis—Prednisone—systemic scleroderma	0.0002	0.000465	CcSEcCtD
Alosetron—Headache—Prednisone—systemic scleroderma	0.000199	0.000462	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—systemic scleroderma	0.000196	0.000454	CcSEcCtD
Alosetron—Asthenia—Methotrexate—systemic scleroderma	0.000191	0.000442	CcSEcCtD
Alosetron—Nausea—Prednisone—systemic scleroderma	0.000189	0.000438	CcSEcCtD
Alosetron—Vomiting—Methotrexate—systemic scleroderma	0.000169	0.000392	CcSEcCtD
Alosetron—Rash—Methotrexate—systemic scleroderma	0.000168	0.000389	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—systemic scleroderma	0.000167	0.000388	CcSEcCtD
Alosetron—Headache—Methotrexate—systemic scleroderma	0.000166	0.000386	CcSEcCtD
Alosetron—Nausea—Methotrexate—systemic scleroderma	0.000158	0.000366	CcSEcCtD
